As well as their possible use in the diagnosis and prognosis of breast cancer recurrence, it has been shown that blocking the CXCR4/SDF-1α axis inhibits the growth of breast cancer in vivo and in vitro [27]. Here, CXCL12 is linked to breast carcinoma.